MYCN and neuroblastoma: Wang and colleagues identified only 3 neuroblastomas harboring ALK amplifications, all also harboring MYCN amplifications, in a cohort of 188 primary neuroblastomas from a patient cohort treated at the Beijing Children’s Hospital [62].